0
0
9/21/23 at 6:48am
Organization
Pharmacytimes.com
32 words
0
Comments
With respiratory syncytial virus vaccine development for infants and children proceeding slowly, therapeutic developers have focused on passive immunity
You are the first to view
https://www.pharmacytimes.com/view/from-setbacks-to-solutions-pioneering-safe-rsv-vaccines-for-infants-children
Create an account
or login to join the discussion